MegaMD Co., Ltd. (KOSDAQ:133750)
South Korea · Delayed Price · Currency is KRW 1,856.00
+3.00 (0.16%)
At close: Jan 30, 2026
MegaMD Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 35,193 | 36,491 | 36,041 | 64,468 | 79,435 | 82,440 |
Other Revenue | - | - | - | -0 | - | - |
| 35,193 | 36,491 | 36,041 | 64,468 | 79,435 | 82,440 | |
Revenue Growth (YoY) | -1.80% | 1.25% | -44.09% | -18.84% | -3.65% | 2.57% |
Cost of Revenue | 14,302 | 14,637 | 16,007 | 25,466 | 30,544 | 31,626 |
Gross Profit | 20,892 | 21,855 | 20,034 | 39,002 | 48,891 | 50,814 |
Selling, General & Admin | 14,690 | 14,559 | 18,232 | 28,714 | 31,290 | 32,646 |
Amortization of Goodwill & Intangibles | 353.51 | 332.69 | 251.29 | 193.82 | 278.27 | 463.82 |
Other Operating Expenses | 403.84 | 379.35 | 458.57 | 676.02 | 691.51 | 712.54 |
Operating Expenses | 19,734 | 19,540 | 23,933 | 37,085 | 42,408 | 43,472 |
Operating Income | 1,157 | 2,315 | -3,899 | 1,918 | 6,484 | 7,341 |
Interest Expense | -223.4 | -240.69 | -291.92 | -286.41 | -269.89 | -260.79 |
Interest & Investment Income | 1,649 | 1,676 | 1,677 | 1,346 | 874.27 | 914.93 |
Earnings From Equity Investments | 877.69 | -505.66 | 36.32 | -36.32 | - | - |
Other Non Operating Income (Expenses) | -54.41 | -84.51 | -436.34 | 386.51 | 291.14 | 10.64 |
EBT Excluding Unusual Items | 3,406 | 3,160 | -2,914 | 3,328 | 7,379 | 8,006 |
Impairment of Goodwill | - | - | - | - | -2,765 | -838.11 |
Gain (Loss) on Sale of Investments | -1,353 | -494.51 | 1,480 | -110.94 | 3,586 | 429.93 |
Gain (Loss) on Sale of Assets | 2,115 | 2,275 | -448.42 | -442.08 | -153.34 | -306.9 |
Asset Writedown | -130.15 | -130.15 | -1,294 | -134.02 | -111.08 | -22.71 |
Pretax Income | 4,038 | 4,810 | -3,177 | 2,641 | 7,935 | 7,268 |
Income Tax Expense | 896.59 | 1,027 | 19.92 | 527.83 | 1,285 | 2,383 |
Earnings From Continuing Operations | 3,141 | 3,783 | -3,197 | 2,113 | 6,650 | 4,885 |
Net Income to Company | 3,141 | 3,783 | -3,197 | 2,113 | 6,650 | 4,885 |
Minority Interest in Earnings | - | - | - | - | - | 12.34 |
Net Income | 3,141 | 3,783 | -3,197 | 2,113 | 6,650 | 4,897 |
Net Income to Common | 3,141 | 3,783 | -3,197 | 2,113 | 6,650 | 4,897 |
Net Income Growth | 138.77% | - | - | -68.23% | 35.79% | 1085.14% |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Change (YoY) | - | - | -0.12% | -0.23% | 0.66% | 3.63% |
EPS (Basic) | 142.29 | 171.39 | -144.83 | 95.71 | 301.26 | 223.84 |
EPS (Diluted) | 141.00 | 171.00 | -145.00 | 95.71 | 300.00 | 223.00 |
EPS Growth | 136.60% | - | - | -68.10% | 34.53% | 1073.68% |
Free Cash Flow | 3,935 | 8,105 | -1,428 | -9,772 | 15,814 | 13,866 |
Free Cash Flow Per Share | 178.25 | 367.18 | -64.70 | -442.15 | 713.89 | 630.07 |
Dividend Per Share | 60.000 | 60.000 | - | - | 150.000 | 100.000 |
Dividend Growth | - | - | - | - | 50.00% | 100.00% |
Gross Margin | 59.36% | 59.89% | 55.59% | 60.50% | 61.55% | 61.64% |
Operating Margin | 3.29% | 6.34% | -10.82% | 2.97% | 8.16% | 8.91% |
Profit Margin | 8.92% | 10.37% | -8.87% | 3.28% | 8.37% | 5.94% |
Free Cash Flow Margin | 11.18% | 22.21% | -3.96% | -15.16% | 19.91% | 16.82% |
EBITDA | 6,225 | 7,409 | 2,010 | 11,190 | 18,260 | 19,511 |
EBITDA Margin | 17.69% | 20.30% | 5.58% | 17.36% | 22.99% | 23.67% |
D&A For EBITDA | 5,068 | 5,094 | 5,909 | 9,272 | 11,776 | 12,169 |
EBIT | 1,157 | 2,315 | -3,899 | 1,918 | 6,484 | 7,341 |
EBIT Margin | 3.29% | 6.34% | -10.82% | 2.97% | 8.16% | 8.91% |
Effective Tax Rate | 22.21% | 21.35% | - | 19.99% | 16.19% | 32.79% |
Advertising Expenses | - | 1,511 | 2,361 | 4,222 | 4,296 | 3,876 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.